Pre commercialization biotechnology companies always burn cash. It is the nature of the business. It can take decades to bring new therapies to market, as the FDA has a high bar for approval. However if there is a nod from the FDA for an early approval, then raising cash is much easier. With the announcements made already this year, Silviu can easily do a road show and raise whatever he needs for MSB.
Biotech companies have some of the wildest rides in the market. I think this one shall be an epic one ))
Pre commercialization biotechnology companies always burn cash....
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.03 | $7.869M | 7.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16411 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 3952 | 2 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.03 |
Change
-0.040 ( 3.65 %) |
||||
| Open | High | Low | Volume | ||
| $1.07 | $1.08 | $1.03 | 1907057 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| MSB (ASX) Chart |